# PREGABALIN
> **ANDA213226** · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2021-04-13
## Drug
- **FDA Application Number:** ANDA213226
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PREGABALIN
- **Generic name:** PREGABALIN
- **Active ingredients:** PREGABALIN
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSN
- **Manufacturer:** Novadoz Pharmaceuticals LLC
- **First approval:** 2021-04-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213226)
---
*MORVS · CC0 1.0*